Vimarsana
Biggest News Aggregation in the World

Page 4 - Human Frontier Science Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Human Frontier Science Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Human Frontier Science Program Today - Breaking & Trending Today

Analysis of brain tumor blood vessels yields a candidate therapy—and a platform to find more - Vimarsana News

Analysis of brain tumor blood vessels yields a candidate therapy—and a platform to find more

A Ludwig Cancer Research study has generated a granular portrait of how the cellular and molecular components of the blood vessels that feed brain metastases of

Astrocyte Study Ties Vitamin B12 to Multiple Sclerosis Progression - Vimarsana News

Astrocyte Study Ties Vitamin B12 to Multiple Sclerosis Progression

A new study uncovers a molecular connection between vitamin B12 and multiple sclerosis (MS).

'Friendly' hyenas are more likely to form mob - Vimarsana News

'Friendly' hyenas are more likely to form mob

<p>Michigan State University researchers have shown that relationships and social interactions between hyenas influence when they &ldquo;mob&rdquo; lions.</p>

Hyena 'buddies' gang up to fight lions - Vimarsana News

Hyena 'buddies' gang up to fight lions

"If hyenas greet each other, they're more likely to mob. If they have strong social bonds, they're more likely to mob."

How a mutation in microglia elevates Alzheimer's risk | MIT News | Massachusetts Institute of Technology - Vimarsana News

How a mutation in microglia elevates Alzheimer's risk | MIT News | Massachusetts Institute of Technology

New MIT research shows that human microglia with the R47H/+ mutation in the TREM2 protein exhibit several deficits related to Alzheimer’s pathology. Mutant microglia are prone to inflammation, yet are worse at responding to neuron injury and less able to clear harmful debris, including amyloid beta.

Source: mit.edu